Neola Medical (Sweden) Performance
| NEOLA Stock | 2.36 0.16 7.27% |
The company secures a Beta (Market Risk) of 0.0323, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Neola Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Neola Medical is expected to be smaller as well. At this point, Neola Medical AB has a negative expected return of -0.17%. Please make sure to verify Neola Medical's kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Neola Medical AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Neola Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Neola |
Neola Medical Relative Risk vs. Return Landscape
If you would invest 282.00 in Neola Medical AB on September 8, 2024 and sell it today you would lose (46.00) from holding Neola Medical AB or give up 16.31% of portfolio value over 90 days. Neola Medical AB is generating negative expected returns and assumes 4.5316% volatility on return distribution over the 90 days horizon. Simply put, 40% of stocks are less volatile than Neola, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Neola Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neola Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Neola Medical AB, and traders can use it to determine the average amount a Neola Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0385
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NEOLA |
Estimated Market Risk
| 4.53 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Neola Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neola Medical by adding Neola Medical to a well-diversified portfolio.
Neola Medical Fundamentals Growth
Neola Stock prices reflect investors' perceptions of the future prospects and financial health of Neola Medical, and Neola Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neola Stock performance.
| Return On Equity | -0.23 | |||
| Return On Asset | -0.12 | |||
| Profit Margin | (0.82) % | |||
| Operating Margin | (0.82) % | |||
| Current Valuation | 69.42 M | |||
| Shares Outstanding | 55.69 M | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 7.03 X | |||
| Revenue | 11.05 M | |||
| EBITDA | (8.59 M) | |||
| Book Value Per Share | 1.58 X | |||
About Neola Medical Performance
Assessing Neola Medical's fundamental ratios provides investors with valuable insights into Neola Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Neola Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Neola Medical AB performance evaluation
Checking the ongoing alerts about Neola Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neola Medical AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Neola Medical AB generated a negative expected return over the last 90 days | |
| Neola Medical AB has high historical volatility and very poor performance | |
| Neola Medical AB has high likelihood to experience some financial distress in the next 2 years | |
| About 73.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Neola Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neola Medical's stock is overvalued or undervalued compared to its peers.
- Examining Neola Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neola Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neola Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neola Medical's stock. These opinions can provide insight into Neola Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Neola Stock Analysis
When running Neola Medical's price analysis, check to measure Neola Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neola Medical is operating at the current time. Most of Neola Medical's value examination focuses on studying past and present price action to predict the probability of Neola Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neola Medical's price. Additionally, you may evaluate how the addition of Neola Medical to your portfolios can decrease your overall portfolio volatility.